Bone regeneration capacity of magnesium phosphate cements in a large animal model

Acta Biomater. 2018 Mar 15:69:352-361. doi: 10.1016/j.actbio.2018.01.035. Epub 2018 Feb 2.

Abstract

Magnesium phosphate minerals have captured increasing attention during the past years as suitable alternatives for calcium phosphate bone replacement materials. Here, we investigated the degradation and bone regeneration capacity of experimental struvite (MgNH4PO4·6H2O) forming magnesium phosphate cements in two different orthotopic ovine implantation models. Cements formed at powder to liquid ratios (PLR) of 2.0 and 3.0 g ml-1 were implanted into trabecular bone using a non-load-bearing femoral drill-hole model and a load-bearing tibial defect model. After 4, 7 and 10 months the implants were retrieved and cement degradation and new bone formation was analyzed by micro-computed tomography (µCT) and histomorphometry. The results showed cement degradation in concert with new bone formation at both defect locations. Both cements were almost completely degraded after 10 months. The struvite cement formed with a PLR of 2.0 g ml-1 exhibited a slightly accelerated degradation kinetics compared to the cement with a PLR of 3.0 g ml-1. Tartrat-resistant acid phosphatase (TRAP) staining indicated osteoclastic resorption at the cement surface. Energy dispersive X-ray analysis (EDX) revealed that small residual cement particles were mostly accumulated in the bone marrow in between newly formed bone trabeculae. Mechanical loading did not significantly increase bone formation associated with cement degradation. Concluding, struvite-forming cements might be promising bone replacement materials due to their good degradation which is coupled with new bone formation.

Statement of significance: Recently, the interest in magnesium phosphate cements (MPC) for bone substitution increased, as they exhibit high initial strength, comparably elevated degradation potential and the release of valuable magnesium ions. However, only few in vivo studies, mostly including non-load-bearing defects in small animals, have been performed to analyze the degradation and regeneration capability of MPC derived compounds. The present study examined the in vivo behavior of magnesiumammoniumphosphate hexahydrate (struvite) implants with different porosity in both mechanically loaded and non-loaded defects of merino sheep. For the first time, the effect of mechanical stimuli on the biological outcome of this clinically relevant replacement material is shown and directly compared to the conventional unloaded defect situation in a large animal model.

Keywords: In vivo; Magnesium phosphate cement; Resorption; Struvite.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Cements* / chemistry
  • Bone Cements* / pharmacokinetics
  • Bone Cements* / pharmacology
  • Bone Regeneration / drug effects*
  • Cancellous Bone* / injuries
  • Cancellous Bone* / metabolism
  • Cancellous Bone* / pathology
  • Disease Models, Animal
  • Female
  • Femur* / injuries
  • Femur* / metabolism
  • Femur* / pathology
  • Magnesium Compounds* / chemistry
  • Magnesium Compounds* / pharmacokinetics
  • Magnesium Compounds* / pharmacology
  • Phosphates* / chemistry
  • Phosphates* / pharmacokinetics
  • Phosphates* / pharmacology
  • Sheep

Substances

  • Bone Cements
  • Magnesium Compounds
  • Phosphates
  • magnesium phosphate